Arthritis Research and Therapy… Spring 2026 Press Review – Arthritis Research & Therapy 26 Apr 202626 Apr 2026 December 2025 to March 2026 Author: Victoria Sadovici-Bobeica Difficult-to-manage axial spondyloarthritis: comorbidity burden and long-term outcomes Bertsias A et al. in this prospective cohort study of 434 patients with axial spondyloarthritis…
Press Review… Spring 2026 Press Review – The Lancet Rheumatology 26 Apr 2026 December 2025 to March 2026 Author: Victoria Sadovici-Bobeica STAMP trial: intensive biologic-first vs standard care in psoriatic arthritis (1-year RCT results) Koc GH et al. in this randomized trial of 120…
Arthritis Research and Therapy… Winter 2026 Press Review – Arthritis Research & Therapy 18 Jan 2026 August 2025 to November 2025 Author: Nikolaos Vlachogiannis IL-17A Blockade Modulates Inflammatory and Stromal Pathwaysin Peripheral Spondyloarthritis Ihsan Hammoura et al. (10.1186/s13075-025-03638-0) found that IL-17A inhibition (IL-17Ai) profoundly alters synovial gene…
Press Review… Winter 2026 Press Review – The Lancet Rheumatology 18 Jan 2026 August 2025 to November 2025 Author: Nikolaos Vlachogiannis Effectiveness of treat-to-target tapering of TNF inhibitors in spondyloarthritides: a 24-month follow-up study Amy C D Peeters et al. (10.1016/s2665-9913(25)00070-0) examined whether a…
Press Review… Autumn 2025 Press Review – Arthritis Research & Therapy 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Curtis…
Press Review… Autumn 2025 Press Review – The Lancet Rheumatology 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Baricitinib in early polymyalgia rheumatic (BACHELOR): a randomised, double-blind, placebo-controlled, parallel group trial Saraux A, et al. (10.1016/S2665-9913(24)00270-4) aimed to test whether baricitinib…
Miscellaneous… Autumn 2025 Press Review – Miscellanous 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Victoria Konzett Upadacitinib FDA and EMA-approved for treatment of giant cell arteritis after positive results from the SELECT-GCA study Blockmans et al. (10.1056/NEJMoa2413449) compared Upadacitinib…
Press Review… Spring 2025 Press Review – Lancet Rheumatology 12 May 2025 December 2024 to March 2025 Author: Antony Psarras and Rositsa Dacheva Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised,…
Press Review… Winter 2025 Press Review – Lancet Rheumatology 2 Feb 2025 August 2024 to November 2024 Authors: Halbert Hernández Negrin and Magda Osipyan Nirmatrelvir–Ritonavir Reduces Mortality and Sequelae in Immunocompromised COVID-19 Patients Lin et al. (10.1016/S2665-9913(24)00224-8) investigated the impact of nirmatrelvir–ritonavir…
Press Review… Autumn 2024 Press Review – Lancet Rheumatology 8 Oct 20249 Oct 2024 April 2024 to July 2024 Author: Olivier Fakih & Roba Ghossan Lancet Rheumatology Identification of distinct subgroups of Sjögren's disease by cluster analysis Nguyen et al. (10.1016/S2665-9913(23)00340-5) aimed to identify distinct…